The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Definitions and guidelines for research on antibiotic persistence
Open accessAbstract
Increasing concerns about the rising rates of antibiotic therapy failure and advances in single-cell analyses have inspired a surge of research into antibiotic persistence. Bacterial persister cells represent a subpopulation of cells that can survive intensive antibiotic treatment without being resistant. Several approaches have emerged to define and measure persistence, and it is now time to agree on the basic definition of persistence and its relation to the other mechanisms by which bacteria survive exposure to bactericidal antibiotic treatments, such as antibiotic resistance, heteroresistance or tolerance. In this Consensus Statement, we provide definitions of persistence phenomena, distinguish between triggered and spontaneous persistence and provide a guide to measuring persistence. Antibiotic persistence is not only an interesting example of non-genetic single-cell heterogeneity, it may also have a role in the failure of antibiotic treatments. Therefore, it is our hope that the guidelines outlined in this article will pave the way for better characterization of antibiotic persistence and for understanding its relevance to clinical outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Persistent strain and susceptible strain take similar time to reach the minimum duration of treatment that kills 99% of the population (MDK99), because initially most of the persistent strain population is susceptible to antifungal treatment and is eliminated in a manner similar to a susceptible strain.”
From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, resistance is linked to specific molecular mechanisms and can be stably inherited by progeny [15,17–19].”
From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Antifungal persistence is a heterogeneous trait, where only a small fraction of the population (generally <<1%) is able to survive drug exposure, while the majority of non-persistent cells are rapidly killed by the treatment.”
From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For a long time, characteristic biphasic-killing curve observed in the time-kill assay and survival rate evaluated by colony-forming unit (CFU) counting were the only ways to identify and evaluate antifungal persistence in vitro [15,20].”
From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Over time, the persistent subpopulation emerges and maintains viability, leading to longer minimum treatment durations required for 99.99% population eradication (MDK99.99) [15,17,20,21] (Fig 1).”
From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [15]
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular mechanisms of antibiotic resistance
Blair, J. M. A., Webber, M. A., Baylay, A. J., Ogbolu, D. O., & Piddock, L. J. V. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3380 · Cited by 4,092
Bacterial Persistence as a Phenotypic Switch
Balaban, N. Q., Merrin, J., Chait, R., Kowalik, L., & Leibler, S. (2004) · Science · doi:10.1126/science.1099390 · Cited by 2,952
Self-citationJacoby, G. A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-08 · Cited by 2,165
Persister cells, dormancy and infectious disease
Lewis, K. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1557 · Cited by 2,052
Self-citationDistinguishing between resistance, tolerance and persistence to antibiotic treatment
Brauner, A., Fridman, O., Gefen, O., & Balaban, N. Q. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.34 · Cited by 1,612
Self-citationAntibiotic tolerance facilitates the evolution of resistance
Levin-Reisman, I., Ronin, I., Gefen, O., Braniss, I., Shoresh, N., & Balaban, N. Q. (2017) · Science · doi:10.1126/science.aaj2191 · Cited by 1,251
Self-citationPersistent bacterial infections and persister cells
Fisher, R. A., Gollan, B., & Helaine, S. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.42 · Cited by 1,243
TREATMENT OF STAPHYLOCOCCAL INFECTIONS WITH PENICILLIN BY INTERMITTENT STERILISATION
Bigger, J. (1944) · The Lancet · doi:10.1016/s0140-6736(00)74210-3 · Cited by 1,178
Persister cells and tolerance to antimicrobials
Keren, I., Kaldalu, N., Spoering, A., Wang, Y., & Lewis, K. (2004) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00856-5 · Cited by 1,098
Self-citationMultidrug efflux pumps: structure, function and regulation
Du, D., Wang-Kan, X., Neuberger, A., van Veen, H. W., Pos, K. M., Piddock, L. J. V., & Luisi, B. F. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0048-6 · Cited by 1,055
Research works printed but not linked: 1
- Barry, L. A. et al. Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline Vol. 19 1–3 (Clinical and Laboratory Standards Institute,1999).
Cited by
A Deep Learning Approach to Antibiotic Discovery
Stokes, J. M., Yang, K., Swanson, K., Jin, W., Cubillos-Ruiz, A., Donghia, N. M., MacNair, C. R., French, S., Carfrae, L. A., Bloom-Ackermann, Z., et al. (2020) · Cell · doi:10.1016/j.cell.2020.01.021 · Cited by 2,463
Self-citationAntimicrobial Resistance in ESKAPE Pathogens
De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078
“For example, IS-mediated deactivation of the ompK36 porin in K. pneumoniae results in elevated carbapenem MICs (281).”
BackgroundInfluentialMolecular mechanisms of antibiotic resistance revisited
Darby, E. M., Trampari, E., Siasat, P., Gaya, M. S., Alav, I., Webber, M. A., & Blair, J. M. A. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00820-y · Cited by 1,398
Tolerance and resistance of microbial biofilms
Ciofu, O., Moser, C., Jensen, P. Ø., & Høiby, N. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00682-4 · Cited by 1,124
Tackling the emerging threat of antifungal resistance to human health
Fisher, M. C., Alastruey-Izquierdo, A., Berman, J., Bicanic, T., Bignell, E. M., Bowyer, P., Bromley, M., Brüggemann, R., Garber, G., Cornely, O. A., et al. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00720-1 · Cited by 1,179
Metadata
- Authors
- Balaban, N. Q., Helaine, S., Lewis, K., Ackermann, M., Aldridge, B., Andersson, D. I., Brynildsen, M. P., Bumann, D., Camilli, A., Collins, J. J., Dehio, C., Fortune, S., Ghigo, J.-M., Hardt, W.-D., Harms, A., Heinemann, M., Hung, D. T., Jenal, U., Levin, B. R., Michiels, J., Storz, G., Tan, M.-W., Tenson, T., Van Melderen, L., & Zinkernagel, A.
- Affiliations
- Hebrew University of Jerusalem (IL)
- Northeastern University (US)
- ETH Zurich (CH)
- Tufts University (US)
- Uppsala University (SE)
- Princeton University (US)
- University of Basel (CH)
- Broad Institute (US)
- Harvard University (US)
- Institut Pasteur (FR)
- University of Groningen (NL)
- Emory University (US)
- VIB-KU Leuven Center for Microbiology (BE)
- National Institutes of Health (US)
- Genentech (US)
- University of Tartu (EE)
- University of Zurich (CH)
- Corresponding author
- Balaban, Nathalie Q.
- ORCID
- Balaban, Nathalie Q.
- Helaine, Sophie
- Lewis, Kim
- Ackermann, Martin
- Aldridge, Bree
- Andersson, Dan I.
- Brynildsen, Mark P.
- Bumann, Dirk
- Camilli, Andrew
- Collins, James J.
- Dehio, Christoph
- Fortune, Sarah
- Ghigo, Jean-Marc
- Hardt, Wolf-Dietrich
- Harms, Alexander
- Heinemann, Matthias
- Hung, Deborah T.
- Jenal, Urs
- Levin, Bruce R.
- Michiels, Jan
- Storz, Gisela
- Tan, Man-Wah
- Tenson, Tanel
- Zinkernagel, Annelies
- Venue
- Nature Reviews Microbiology
- Published
- 2019-04-12
- Volume
- 17
- Issue
- 7
- Pages
- 441-448
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- PMC
- PMC7136161
- OpenAlex
- W2940117744
- Cited by
- 1,313
- References
- 58
- Citations by year
- 2026: 188 · 2025: 194 · 2024: 226 · 2023: 167 · 2022: 184 · 2021: 160 · 2020: 144 · 2019: 46
- FWCI
- 17.87
- Type
- journal article
- Language
- en
- Update notices
- correction (2019-04-29)
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Reviews Microbiology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Repository for Publications and Research Data (ETH Zurich) (publishedVersion, cc-by)
- HAL (submittedVersion, cc-by)
- DORA Eawag (Swiss Federal Institute of Aquatic Science and Technology (Eawag)) (submittedVersion, cc-by)
- Lirias (KU Leuven) (submittedVersion, cc-by)
- Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- edoc (University of Basel) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- ETH Zürich Research Collection (cc-by)
- Funders
- European Molecular Biology Organization
- Universität Basel
- Federation of European Microbiological Societies
- National Institutes of Health (R01GM)
- Medical Research Council (MR/P028225/1)
- National Institute of General Medical Sciences (R01GM091875)
- National Institute of Allergy and Infectious Diseases (R01AI055058, R37AI055058)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Keywords
- antibiotic persistence, persister cells, heteroresistance, antibiotic tolerance, antibiotic resistance, single-cell heterogeneity, antibiotic treatment failure, bacterial survival
- MeSH terms
- Anti-Bacterial Agents, Bacteria, Drug Tolerance, Terminology as Topic, Guidelines as Topic, Biomedical Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Definitions and guidelines for research on antibiotic persistence. https://app.cochat.ai/papers/10.1038/s41579-019-0196-3
- The paper
- Balaban, N. Q., Helaine, S., Lewis, K., Ackermann, M., Aldridge, B., Andersson, D. I., Brynildsen, M. P., Bumann, D., Camilli, A., Collins, J. J., Dehio, C., Fortune, S., Ghigo, J.-M., Hardt, W.-D., Harms, A., Heinemann, M., Hung, D. T., Jenal, U., Levin, B. R., . . . Zinkernagel, A. (2019). Definitions and guidelines for research on antibiotic persistence. Nature Reviews Microbiology. https://doi.org/10.1038/s41579-019-0196-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.